Intuitive Surgical has delivered a 57.6% gain over the past three years, which puts a lot of weight on one question for you as a shareholder or prospective buyer. Is the current US$436.87 share price adequately backed by the cash the business is expected to generate?
- That 57.6% return over three years means a lot of future performance is already embedded in the share price. The key issue is whether the company’s cash flows are strong and durable enough to support it.
- The business leans on a recurring stream of procedure and service revenue from its installed base of surgical systems. This can support more predictable cash generation and makes the timing and stability of future cash flows central to any valuation work.
- What if you looked at Intuitive Surgical through its earnings instead? See why Intuitive Surgical's 51.2x P/E tells a different valuation story.
The issue now is whether the stream of cash flows implied by Intuitive Surgical’s operations can justify where the stock trades today.
If you want more context around Intuitive Surgical and cash flow driven valuations, compare it with companies filtered through 34 high quality undervalued stocks
Is Intuitive Surgical Fairly Priced on Cash Flow?
The Discounted Cash Flow (DCF) model here projects the cash that Intuitive Surgical could return to shareholders based on its current operations and expected trajectory. Over the last twelve months, the group produced around $3.13b in free cash flow, and analyst projections assume that this figure continues to grow rather than shrink over the coming decade.
Those estimates build in rising free cash flow into the 2030s, then taper the growth rate to reflect a more mature profile instead of perpetual rapid expansion. When those cash flows are discounted back and compared with today’s US$436.87 share price, the DCF output suggests Intuitive Surgical trades broadly in line with what its projected cash generation can support. Find out what Intuitive Surgical could be worth using our Discounted Cash Flow (DCF) estimate.
The Intuitive Surgical Narrative: What Would Justify Today's Price?
Narratives pick up where the DCF puzzle leaves off for Intuitive Surgical. They spell out which paths for growth, margins and earnings would need to play out for the stock to be worth materially more or less than today’s price, and each one links a fair value to a specific storyline about potential catalysts and risks so you can later assess which version of events is actually unfolding on the Community page.
Community views on Intuitive Surgical split between those who see a resilient cash engine and those who worry the expectations built into the price leave little cushion.
Bull case: 18% undervalued
"ISRG’s robust business model and strong moat come from this recurring revenue, as hospitals must continuously purchase instruments, maintenance services, and software updates..."
Discover why this Narrative puts Intuitive Surgical at 18% undervalued.
Bear case: 31% overvalued
"The current numbers imply that Intuitive Surgical’s share price already reflects strong procedure growth, high margins and successful platform expansion, which leaves limited room for disappointment..."
Explore why this Narrative puts Intuitive Surgical at 31% overvalued.
One more angle on Intuitive Surgical that could change the story
Cash flows tell you what Intuitive Surgical currently supports, but the people steering the business and the way their rewards are structured can heavily influence what happens next. See who runs Intuitive Surgical and how they are paid.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com